Vital Therapies lowers the bar in its 2nd try at an initial public offering, aiming to raise up to $68 million this time around.
Bio-artificial liver maker Vital Therapies set the range for its initial public offering at $13 to $15 per share, below the $16 to $18 range it set last year before scuttling its 1st try at a U.S. IPO.
Help employers find you! Check out all the jobs and post your resume.
